TAMOXIFEN PLUS BROMOCRIPTINE VERSUS TAMOXIFEN PLUS PLACEBO IN ADVANCED BREAST-CANCER - RESULTS OF A DOUBLE-BLIND MULTICENTER CLINICAL-TRIAL

被引：41

作者：

BONNETERRE, J

MAURIAC, L

WEBER, B

ROCHE, H

FARGEOT, P

TUBIANAHULIN, M

SEVIN, M

CHOLLET, P

CAPPELAERE, P

机构：

[1] FDN BERGONIE,F-33076 BORDEAUX,FRANCE

[2] CTR ALEXIS VAUTRIN,F-54511 VANDOEUVRES NANCY,FRANCE

[3] CTR CLAUDIUS REGAUD,F-31052 TOULOUSE,FRANCE

[4] CTR GEORGES FRANCOIS LECLERC,F-21034 DIJON,FRANCE

[5] CTR RENE HUGUENIN,F-92211 ST CLOUD,FRANCE

[6] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE

[7] CTR JEAN PERRIN,F-63011 CLERMONT FERRAND,FRANCE

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 12期

关键词：

D O I：

10.1016/0277-5379(88)90097-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1851 / 1853

页数：3

共 9 条

[1] CORRELATION BETWEEN PROLACTIN RECEPTORS (PRL R), ESTRADIOL (ER) AND PROGESTERONE RECEPTORS (PGR) IN HUMAN-BREAST CANCER [J].

BONNETERRE, J ;

PEYRAT, JP ;

BEUSCART, R ;

DEMAILLE, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11) :1331-1336

[2] PROLACTIN RECEPTORS IN HUMAN-BREAST CANCER [J].

BONNETERRE, J ;

PEYRAT, JP ;

VANDEWALLE, B ;

BEUSCART, R ;

VIE, MC ;

CAPPELAERE, P .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (11) :1157-1162

[3]

DELLACUNA GR, 1986, 14TH INT CANC C BUD

[4] EVIDENCE THAT HUMAN GROWTH-HORMONE IS A POTENT LACTOGEN IN PRIMATES [J].

KLEINBERG, DL ;

TODD, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (05) :1009-1013

[5]

PATTERSON AG, 1983, EUR J CANCER CLIN ON, V19, P919

[6]

PEYRAT JP, 1984, ANTICANCER RES, V4, P257

[7] EFFECT OF BROMOCRIPTIN TREATMENT ON PROLACTIN AND STEROID-RECEPTOR LEVELS IN HUMAN-BREAST CANCER [J].

PEYRAT, JP ;

VENNIN, P ;

BONNETERRE, J ;

HECQUET, B ;

VANDEWALLE, B ;

KELLY, PA ;

DJIANE, J .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (11) :1363-1367

[8]

WARD HWC, 1977, CLIN ONCOL, V3, P91

[9]

1972, EUR J CANCER, V8, P155

← 1 →